Suchergebnisse - "Herrington, William G"

PubPharm (9)

1

Impact of outcome adjudication in kidney disease trials : observations from the Study of Heart and Renal Protection (SHARP)

enthalten in: Kidney international reports | 2023

von Herrington, W. | Harper, C. | Staplin, N. | +9

2

SGLT2 inhibitors in CKD and HFpEF : two new large trials and two new meta-analyses

enthalten in: The British journal of cardiology | 2023

von Mayne, K. | Preiss, D. | Herrington, W.

3

Bioimpedance Indices of Fluid Overload and Cardiorenal Outcomes in Heart Failure and Chronic Kidney Disease : a Systematic Review

enthalten in: Journal of cardiac failure | 2022

von Mayne, K. | Shemilt, R. | Keane, D. | +3

4

Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression

enthalten in: Journal of the American Society of Nephrology : JASN | 2022

von Neuen, B. | Tighiouart, H. | Heerspink, H. | +25

5

Conventional and Genetic Evidence on the Association between Adiposity and CKD

enthalten in: Journal of the American Society of Nephrology : JASN | 2021

von Zhu, P. | Herrington, W. | Haynes, R. | +7

6

Socioeconomic disadvantage and the risk of advanced chronic kidney disease : results from a cohort study with 1.4 million participants

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2020

von Weldegiorgis, M. | Smith, M. | Herrington, W. | +2

7

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2020

von Lamprea-Montealegre, J. | Staplin, N. | Herrington, W. | +5

CommentIn: Clin J Am Soc Nephrol. 2020 Jan 7;15(1):5-7. - PMID 31846933

8

Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease

enthalten in: Circulation | 2018

von Haynes, R. | Judge, P. | Staplin, N. | +13

CommentIn: Circulation. 2018 Oct 9;138(15):1515-1518. - PMID 30354525

9

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases : A Meta-Analysis

enthalten in: Journal of the American Society of Nephrology : JASN | 2018

von Marthi, A. | Donovan, K. | Haynes, R. | +11

1
[1]